Nucleoside analogues in the treatment of haematological malignancies

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 929-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Nucleoside Analogues: Focus on Haematological Malignancies

By Johnson S.A.

Clinical Pharmacokinetics, Vol. 39, Iss. 1, 2000-07 ,pp. : 5-26

Adis International

Access to resources Recommend Favorite

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 421-444

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly

Current Pharmaceutical Design, Vol. 16, Iss. 26, 2010-09 ,pp. : 2872-2879

Bentham Science Publishers

Access to resources Recommend Favorite